‘These findings provide clinicians with evidence to embrace moderate-intensity aerobic exercise as a standard coadjutant therapy targeting this patient population.’ The authors state.
View More Exercise training effective in reducing ambulatory blood pressure in resistant hypertension, results from the EnRicH trial
By Elisabeth Mahase Taken Directly from the BMJ doi: https://doi.org/10.1136/bmj.n1898 Criticisms of the US Food and Drug Administration’s accelerated approval process have resurfaced after the recent…
View More FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway
The aim of this study was to investigate the causal relationship and evidence of an association between increased adiposity and the risk of incident cardiovascular disease (CVD) events or mortality.
View More Impact of adiposity on cardiovascular outcomes: an umbrella review and meta-analysis provides updated insights
The British Cardiovascular Society (BCS) has today released a Joint Statement together with the British Heart Valve Society (BHVS), the Society for Cardiothoracic Surgeons (SCTS),…
View More Anticoagulation of Patients with Mechanical Heart Valves.
By Saadia Aslam Original research from Professor Markus Schwerzmann and his team collected clinical outcome data to help identify risk factors for a complicated course…
View More Clinical outcome of COVID-19 in patients with adult congenital heart disease
By Sean Zheng Key messages Heart failure with preserved ejection fraction (HFPEF) is a common cause of hospitalisation, impaired quality of life, restricted functional capacity,…
View More Heart failure with preserved ejection fraction
By Syed Ghias Take Home Messages Coronary computed tomographic angiography (CCTA) is a well-established non-invasive diagnostic modality which reliably rules out obstructive coronary artery disease…
View More Utility of CT coronary angiography in non-ST elevation acute coronary syndrome
By Syed Ghias Take Home Messages Sodium-glucose co-transporter-2 (SGLT-2) inhibitors are a novel class of oral hypoglycaemic medications which have been shown to be effective…
View More Sodium-glucose co-transporter 2 inhibitors – new frontier in the treatment of heart failure
By Ahmed El-Medany Presented by: Dr Fozia Ahmed, Consultant Cardiologist, Manchester Heart Centre The Digital Innovation in Cardiology session at BCS 2021 was a fascinating…
View More Digital solutions to identify worsening heart failure: TRIAGEHF PLUS
By Ahmed El-Medany Weekly subcutaneous injections of efpeglenatide, a novel exendin-based GLP1-RA, have been shown to reduce the risk of major adverse cardiovascular events (MACE)…
View More Efpeglenatide, a novel GLP-1 receptor agonist, reduces cardiovascular events and progression of chronic renal failure in type 2 diabetes